Medgenics Inc


Israel-based Medgenics Inc is a biopharmaceutical company, which has developed a technology that could replace regular injections as a treatment for various ailments. This is described by the company as a biological Biopump. A skin biopsy is taken from a patient and processed for two weeks in order for it to produce the required protein. It is then put back in the body, under the skin. This can provide a sustained dose of the required treatment which can last for weeks or months. The first product is called EPODURE, because it produces EPO (erythro-protein) to treat anaemia. The second product in development is INFRADURE, which is designed for the production and sustained delivery of interferon-alpha for the treatment of hepatitis C. Medgenics joined Aim on 4 December 2007 when it raised £3.276m at 10p a share.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds